|
|
||||||||
Eur J Cardiothorac Surg 2005;28:506
© 2005 Elsevier Science NL
Letter to the Editor |
Pneumology Service, Hospital Universitario 12 de Octubre, Avda. Córdoba s/n, 28041 Madrid, Spain
Received 4 May 2005; accepted 9 May 2005.
* Corresponding author. Tel./fax: +34 91 3908492. (Email: lencuent{at}h12o.es).
Key Words: Lung cancer COPD Molecular Surgery
We are grateful to Spina et al. for their comments concerning our work [1]. In accordance with their hypotheses, it is necessary for the molecular aspect of lung cancer to be studied more thoroughly in general and to deepen into certain subpopulations affected with that neoplasia.
Currently, our sample consisting of 2994 cases of lung cancer from the GCCB-S, is being used to measure the expression of over 30 proteins employing the tissue arrays technology [2]. In doing so, we expect to be able to answer some of the questions raised.
References
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |